Skip to main content
SpringerLink
Log in

Immunosuppressant Therapy is Beneficial in Severe Inflammatory Dermatoses

  • New Drugs and Therapeutics
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Dutz JP, Ho VC. Immunosuppressive agents in skin disorders: a comparative review. Clin Immunother 1996 Apr; 5: 268–93

    Article  Google Scholar 

  2. Fine J-D. Management of acquired bullous skin diseases. N Engl J Med 1995 Nov 30; 333: 1475–84

    Google Scholar 

  3. Aberer W, Wolff-Schreiner EC, Stingl G, et al. Azathioprine in the treatment of pemphigus vulgaris. J Am Acad Dermatol 1987; 16: 527–33

    Article  PubMed  CAS  Google Scholar 

  4. Guillaume JC, Vaillant L, Bernard P, et al. Controlled trial of azathioprine and plasma exchange in addition to prednisolone in the treatment of bullous pemphigoid. Arch Dermatol 1993; 129: 49–53

    Article  PubMed  CAS  Google Scholar 

  5. Nonspecific immunosuppressive therapies still the mainstay for SLE. Drug Ther Perspect 1996 Jul 8; 8 (1): 5–9

    Article  Google Scholar 

  6. Bunch TW, Worthington JW, Coombs J, et al. Azathioprine with prednisolone for polymyositis: a controlled, clinical trial. Ann Intern Med 1980; 92: 365–9

    PubMed  CAS  Google Scholar 

  7. Bunch TW. Prednisolone and azathioprine for polymyositis: longterm followup. Arthritis Rheum 1981; 24: 45–9

    Article  PubMed  CAS  Google Scholar 

  8. Joffe MM, Love LA, Leff RL, et al. Drug therapy of the idiopathic inflammatory myopathies: predictors of response to prednisone, azathioprine, and methotrexate and a comparison of their efficacy. Am J Med 1993 Apr; 94: 379–87

    Article  PubMed  CAS  Google Scholar 

  9. Bombardiere S, Hughes GRV, Neri R, et al. Cyclophosphamide in severe polymyositis. Lancet 1989; i: 1063–6

    Google Scholar 

  10. Leigh IM, Hawk JL. Treatment of chronic actinic dermatitis with azathioprine. Br J Dermatol 1984; 110: 691–5

    Article  PubMed  CAS  Google Scholar 

  11. Murphy GM, Maurice PDL, Norris PG, et al. Azathioprine treatment in chronic actinic dermatitis: a double-blind controlled trial with monitoring of exposure to ultraviolet radiation. Br J Dermatol 1989; 121: 639–46

    Article  PubMed  CAS  Google Scholar 

  12. Younger IR, Harris DWS, Colver GB. Azathioprine in dermatology. J Am Acad Dermatol 1991; 25: 281–6

    Article  PubMed  CAS  Google Scholar 

  13. Immunosuppression is mainstay of therapy for vasculitides. Drug Ther Perspect 1995 Oct 16; 6 (8): 9–11

    Article  Google Scholar 

  14. McDonald CJ. Cytotoxic agents for use in dermatology. I. J Am Acad Dermatol 1985; 12: 753–75

    Article  CAS  Google Scholar 

  15. Rosenbaum M, Roenigk HJ. Treatment of generalized pustular psoriasis with etretinate (Ro-10–9359) and methotrexate. J Am Acad Dermatol 1984; 12: 357

    Article  Google Scholar 

  16. Reitamo S, Erkko P, Remitz A, et al. Cyclosporine in the treatment of palmoplantar pustulosis. Arch Dermatol 1993 Oct; 129: 1273–9

    Article  PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Immunosuppressant Therapy is Beneficial in Severe Inflammatory Dermatoses. Drugs Ther. Perspect 9, 5–9 (1997). https://doi.org/10.2165/00042310-199709020-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-199709020-00002

Keywords

Search

Navigation